A randomized, double-blind, placebo-controlled, multicenter Phase II clinical trial of fruquintinib in patients with metastatic colorectal cancer (mCRC)

作者:Li, J.; Xu, R.; Bai, Y.; Xu, J.; Liu, T.; Shen, L.; Wang, L.; Pan, H.; Fan, S.; Hua, Y.; Su, W.; Hugg, C.
来源:European Cancer Congress, Vienna, AUSTRIA, 2031-09 To 2031-09.
DOI:10.1016/S0959-8049(16)31033-4